Retinoblastoma Incidence in Taiwan Over a Recent 20-Year Period: A Comprehensive Nationwide Study

Hsin-Ying Lin,Chung-Han Ho,Yu-Shiuan Lin,Shu-Chun Kuo,Yi-Chen Chen,Yung-Jen Cheng
DOI: https://doi.org/10.2147/ijgm.s452277
IF: 2.145
2024-03-09
International Journal of General Medicine
Abstract:Hsin-Ying Lin, 1 Chung-Han Ho, 2, 3 Yu-Shiuan Lin, 1 Shu-Chun Kuo, 1, 4 Yi-Chen Chen, 2 Yung-Jen Cheng 5 1 Department of Ophthalmology, Chi Mei Medical Center, Tainan, Taiwan; 2 Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan; 3 Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan; 4 Department of Optometry, Chung Hwa University of Medical Technology, Tainan, Taiwan; 5 Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan Correspondence: Yung-Jen Cheng, Department of Radiation Oncology, National Cheng Kung University Hospital, No. 138, Sheng Li Road, Tainan, 704, Taiwan, Email Purpose: Continuous advancements in medical diagnostic technology and the growing availability of resources suggest a potential for fluctuations in the incidence rate of retinoblastoma (Rb). This study aimed to analyze incidence data of Rb patients in Taiwan from 1999 to 2018, utilizing the nationwide Taiwan Cancer Registry (TCR) database. Additionally, we investigated the treatment modalities used for these Rb patients and compared them with those observed in other countries. Patients and Methods: We conducted a retrospective cohort study utilizing data from the TCR database. The study cohort comprised individuals who were newly diagnosed with Rb between 1999 and 2018. The incidence of Rb was calculated as the number of patients with Rb per million live births, both for the entire population and for different gender groups and time periods. The trends in Rb incidence from 1999 to 2018 across various age groups and sexes were presented with the linear trend test. Results: From 1999 to 2018, a total of 248 cases of Rb were identified. The overall incidence rate over this 20-year period was 60.20 cases per million live births, corresponding to 1 case per 16,611 live births. Incidence rates for each 5-year period between 1999 and 2018 exhibited no significant differences. The study cohort was predominantly male, with 134 cases (54.03%) being males and 114 cases (45.97%) being females, resulting in an overall male-to-female sex ratio of 1.18. Females had lower relative risk than males (RR: 0.92, 95% CI: 0.72– 1.19). Primary surgical intervention was the preferred treatment modality for over 75% of the cases. Conclusion: This retrospective epidemiology study, using TCR from 1999 to 2018, indicated that no discernible trend of retinoblastoma incidence in Taiwan. Nevertheless, continuous monitoring of incidence rates and exploration of treatment strategies for retinoblastoma within the Taiwanese population are important to address potential changes in developing medical practices. Keywords: retinoblastoma, incidence rate, treatment outcome, Taiwan cancer registry Retinoblastoma (Rb), the most prevalent intraocular cancer in children, has the potential to affect one or both eyes. Failure to treat or delay in diagnosing retinoblastoma can result in blindness or even pose a life-threatening risk. The incidence rate of Rb, ranging from 1 per 13,000 to 1 per 24,000 live births, has been reported in various countries worldwide. 1–17 In Taiwan, a retrospective study revealed an incidence rate of 1 per 21,691 live births for Rb during the era of 1980s to 2000s. 18 With the continuous advancements in medical diagnostic technology and the availability of more resources, the incidence rate of Rb may potentially undergo fluctuations. The nationwide Taiwan Cancer Registry database (TCR), which has been organized by the Health Promotion Administration, Ministry of Health and Welfare in Taiwan for over 30 years, recruits over 97% of newly diagnosed cancer and has significantly contributed to the foundation support for academic cancer research and most of the cancer control policies in Taiwan. 19 This database, in comparison to the National Health Insurance Research Database (NHIRD), provides a more comprehensive array of information regarding cancer-specific data, including cancer staging and detailed information on the initial treatment modalities. Utilizing the TCR, this study aimed to analyze the most current incidence data for Rb patients in Taiwan from 1999 to 2018. Furthermore, we sought to investigate the treatment modalities utilized for Rb patients and compare these treatment decisions with those made in other countries. Taiwan Cancer Registry (TCR) from the Health and Welfare Data Science Center (HWDC) were used in this study. TCR is a population-based cancer registry database that has systematically collected cancer-related information sin -Abstract Truncated-
medicine, general & internal
What problem does this paper attempt to address?